FIELD: medicine, pharmaceutical industry. SUBSTANCE: invention relates to development of the novel drugs used for treatment of patients with acute and chronic prostatitis. Rectal agent has cattle prostate gland liquid purified extract as biologically active component and filling agent at the following ratio of components, wt.-%: cattle prostate gland liquid purified extract 46.0-47.0 and filling agent, the balance. EFFECT: broadened arsenal of drugs. 2 cl, 2 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| RECTAL MEANS FOR TREATING CHRONIC PROSTATITIS | 1999 |
|
RU2160114C1 |
| PHARMACEUTICAL COMPOSITION FOR TREATING PROSTATE DISEASES (VERSIONS) | 2009 |
|
RU2430733C2 |
| SUPPOSITORY | 2000 |
|
RU2185817C2 |
| MEANS FOR TREATMENT OF CHRONIC PROSTATITIS | 2007 |
|
RU2342940C1 |
| BIOLOGICALLY ACTIVE PHOSPHOLIPID-COMPRISING COMPLEX FOR TREATMENT OF PSORIASIS AND CHRONIC PROSTATITIS | 2003 |
|
RU2275205C2 |
| PHARMACEUTICAL COMPOSITION FOR TREATING DISEASES OF LOWER PART OF GENITOURINARY SYSTEM | 2010 |
|
RU2428173C1 |
| RECTAL SUPPOSITORIES FOR PROSTATE TREATMENT CONTAINING LYSYL-GLUTAMYL-ASPARTYL-PROLINE TETRAPEPTIDE | 2017 |
|
RU2640931C1 |
| METHOD FOR TREATING PROSTATIC DISEASES | 2005 |
|
RU2304979C2 |
| PROSTACOR SOLUTION FOR MAKING INJECTIONS | 2004 |
|
RU2283646C2 |
| METHOD FOR DETECTING BIOLOGICAL ACTIVITY OF PREPARATIONS MADE OF PROSTATIC TISSUE | 2000 |
|
RU2186387C2 |
